Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Enzymatica Recruits New Director of Quality Assurance

STOCKHOLM, Oct. 10, 2019 /PRNewswire/ -- Enzymatica has hired Åsa Anderlind to serve as Director Quality Assurance and be part of the company's management group. Åsa will be responsible for quality assurance at Enzymatica, including maintenance and streamlining of the processes in the company's ISO 13485 certified quality management system. She has extensive experience at medical device and pharmaceutical companies. Åsa is starting at Enzymatica in October 2019.

Åsa Anderlind comes most recently from QPharma, where she was responsible for GMP training and internal audits. Before that she was Director of Quality Assurance at Euro Diagnostica AB and Wieslab AB (subsidiary) for ten years. She has also held various quality assurance positions at BioInvent, Ferring and Biopool.

"We are extremely pleased to have Åsa Anderlind join us at Enzymatica. With her solid and extensive experience in the field of quality assurance, she will contribute additional key skills in the development of our business, especially in quality assurance related to medical device products," says Fredrik Lindberg, CEO of Enzymatica.

"I look forward to working at Enzymatica, which with its barrier technology has tremendous development potential, especially in international markets," says Åsa Anderlind.

For more information please contact:
Fredrik Lindberg
CEO Enzymatica AB
Tel: +46(0)708-86-53-70
Email: fredrik.lindberg@enzymatica.com

Carl-Johan Wachtmeister
Head of Corporate Communications
Enzymatica AB
Tel: +46 (0)701-88-50-21
Email: carl-johan.wachtmeister@enzymatica.com

Åsa Anderlind
Director of Quality Assurance
Enzymatica AB
Tel: +46 (0)702-616751
Email: asa.anderlind@enzymatica.com

About Enzymatica AB

Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The company's first product is ColdZyme®, which can prevent colds and reduce the duration of disease. The product has been launched in about ten markets. The strategy is to continue to grow by strengthening the Company's position in existing markets and expanding into new geographic markets through established partners. The company has its headquarters in Lund and is listed on Nasdaq First North Growth Market. For more information, visit: www.enzymatica.com and www.enzymatica.se/en/section/media/press-releases.

Enzymatica's Certified Adviser is Erik Penser Bank.
Tel: +46 (0)8-463-83-00
Email: certifiedadviser@penser.se

Enzymatica AB, Ideon Science Park, 223 70 Lund Phone: +46-46-286-31-00, www.enzymatica.se, www.coldzyme.se

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/enzymatica-ab/r/enzymatica-recruits-new-director-of-quality-assurance,c2929511

The following files are available for download:

Tags:




×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.